1582 related articles for article (PubMed ID: 27780211)
21. Treatment guidelines for latent tuberculosis infection.
;
Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study.
Huerga H; Sanchez-Padilla E; Melikyan N; Atshemyan H; Hayrapetyan A; Ulumyan A; Bastard M; Khachatryan N; Hewison C; Varaine F; Bonnet M
Arch Dis Child; 2019 Jul; 104(7):622-628. PubMed ID: 30523172
[TBL] [Abstract][Full Text] [Related]
23. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
Mirzazadeh A; Kahn JG; Haddad MB; Hill AN; Marks SM; Readhead A; Barry PM; Flood J; Mermin JH; Shete PB
PLoS One; 2021; 16(4):e0249012. PubMed ID: 33793612
[TBL] [Abstract][Full Text] [Related]
24. Nationwide survey of drug-resistant tuberculosis in the United States.
Bloch AB; Cauthen GM; Onorato IM; Dansbury KG; Kelly GD; Driver CR; Snider DE
JAMA; 1994 Mar; 271(9):665-71. PubMed ID: 8080502
[TBL] [Abstract][Full Text] [Related]
25. Latent Tuberculosis in Pregnancy: A Systematic Review.
Malhamé I; Cormier M; Sugarman J; Schwartzman K
PLoS One; 2016; 11(5):e0154825. PubMed ID: 27149116
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol.
Bunyasi EW; Schmidt BM; Abdullahi LH; Mulenga H; Tameris M; Luabeya A; Shenje J; Scriba T; Geldenhuys H; Wood R; Hatherill M
BMJ Open; 2017 Mar; 7(3):e014609. PubMed ID: 28283492
[TBL] [Abstract][Full Text] [Related]
27. Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial.
Ntinginya NE; Te Brake L; Sabi I; Chamba N; Kilonzo K; Laizer S; Andia-Biraro I; Kibirige D; Kyazze AP; Ninsiima S; Critchley JA; Romeo R; van de Maat J; Olomi W; Mrema L; Magombola D; Mwayula IH; Sharples K; Hill PC; van Crevel R;
Trials; 2022 Jun; 23(1):480. PubMed ID: 35689272
[TBL] [Abstract][Full Text] [Related]
28. Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study.
Winje BA; Grøneng GM; White RA; Akre P; Aavitsland P; Heldal E
BMJ Open; 2019 Jan; 9(1):e023412. PubMed ID: 30782706
[TBL] [Abstract][Full Text] [Related]
29. Active tuberculosis risk with tumor necrosis factor inhibitors after treating latent tuberculosis.
Kwon M; Sung M; Kwon YJ; Song YG; Lee SW; Park MC; Park YB; Lee SK; Song JJ
J Clin Rheumatol; 2014 Mar; 20(2):68-73. PubMed ID: 24561408
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region.
Ahmad S; Mokaddas E; Al-Mutairi NM
Expert Rev Anti Infect Ther; 2018 Sep; 16(9):709-721. PubMed ID: 30173588
[TBL] [Abstract][Full Text] [Related]
32. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
Marx FM; Hauer B; Menzies NA; Haas W; Perumal N
BMC Public Health; 2021 Nov; 21(1):2172. PubMed ID: 34836526
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and treatment of latent tubercular infections].
Sotgiu G
G Ital Med Lav Ergon; 2010; 32(3):264-8. PubMed ID: 21061707
[TBL] [Abstract][Full Text] [Related]
34. Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection.
Zumla A; Atun R; Maeurer M; Mwaba P; Ma Z; O'Grady J; Bates M; Dheda K; Hoelscher M; Grange J
Trop Med Int Health; 2011 Jan; 16(1):79-83. PubMed ID: 21342371
[TBL] [Abstract][Full Text] [Related]
35. Advances in diagnosis and treatment of latent tuberculosis infection.
Chapman HJ; Lauzardo M
J Am Board Fam Med; 2014; 27(5):704-12. PubMed ID: 25201941
[TBL] [Abstract][Full Text] [Related]
36. Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country.
Sullivan K; Pease C; Zwerling A; Mallick R; Van Dyk D; Mulpuru S; Allen C; Alsdurf H; Alvarez GG
BMC Public Health; 2021 May; 21(1):964. PubMed ID: 34020616
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Latent Tuberculosis Infection Among Non-US-Born Persons by Country of Birth-United States, 2012-2017.
Collins JM; Stout JE; Ayers T; Hill AN; Katz DJ; Ho CS; Blumberg HM; Winglee K;
Clin Infect Dis; 2021 Nov; 73(9):e3468-e3475. PubMed ID: 33137172
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for latent tuberculosis infection in children in South Korea.
Son M; Park YS; Jung MH; Kang JH; Choi UY
Postgrad Med; 2018 Sep; 130(7):637-643. PubMed ID: 30095331
[TBL] [Abstract][Full Text] [Related]
39. Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review.
Abad CLR; Deziel PJ; Razonable RR
Transpl Infect Dis; 2019 Dec; 21(6):e13178. PubMed ID: 31541575
[TBL] [Abstract][Full Text] [Related]
40. Management of multidrug resistant tuberculosis.
Daley CL; Caminero JA
Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
